Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 10Gastrointestinal 10Thoracic 3Sarcoma 2Head & Neck 2Dermatologic 2Other hematologic neoplasm 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Ovarian Neoplasms 23Peritoneal Neoplasms 18Colorectal Neoplasms 10Stomach Neoplasms 9Fallopian Tube Neoplasms 8Endometrial Neoplasms 8Colonic Neoplasms 7Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 6Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Renal Cell 4Appendiceal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Pseudomyxoma Peritonei 2Prostatic Neoplasms 2Neuroblastoma 2Melanoma 2Lung Neoplasms 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Breast Neoplasms 2

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Cyclophosphamide 8Gemcitabine 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Oxaliplatin × Gynecologic × Clear all
NCT01481701 2014-10-15

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Jules Bordet Institute

Phase 2 Completed
90 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡